Specialty

Pharmacoepidemiology, Pharmacoeconomics, Medical statistics, Social pharmacy

Works

Original papers

1 Iketani R, Imai S. Family Pharmacist System for Patients With Chronic Cardiovascular or Endocrine Disease. JAMA Netw Open. 2026;9(2):e2560398.

2 Iketani R. Effectiveness of the kakaritsuke-yakuzaishi (family pharmacist) system for underage individuals in Japan: a cohort study using a health insurance claims database. BMC Health Serv Res. 2025;25(1):1182.

3 Iketani R, Imai S. Prescription Trends for the Antidiabetic Agents Used to Treat Type 2 Diabetes Mellitus in Japan from 2012-2020: a Time-Series Analysis. Biol Pharm Bull. 2023;46(4):592-598.

4 Iketani R, Imai S. Impact of breakthrough trials on prescription trends of sodium-glucose cotransporter-2 inhibitors in Japan: An interrupted time-series analysis. J Clin Pharm Ther. 2022;47(11):1796-1804.

5 Iketani R, Konomura K. Identification of individuals benefiting from the kakaritsuke-yakuzaishi (family pharmacist) system in Japan: a retrospective cohort study using an employment-based health insurance claims database. BMC Health Serv Res. 2022;22(1):682.

6 Iketani R, Furushima D, Imai S, Yamada H. Efficacy and safety of atypical antipsychotics for psychosis in Parkinson’s disease: A systematic review and Bayesian network meta-analysis. Parkinsonism Relat Disord. 2020;78:82-90.

7 Iketani R, Imai S, Horiguchi H, Furushima D, Fushimi K, Yamada H. Risk stratification for physical morbidity using factors associated with atypical antipsychotic treatment in Parkinson’s disease: A retrospective observational study using administrative claims data. J Clin Neurosci. 2020;76:189-194.

8 Iketani R, Imai S, Horiguchi H, Furushima D, Fushimi K, Yamada H. Comparison of the association of risperidone and quetiapine with deteriorating performance in walking and dressing in subjects with Parkinson’s disease: a retrospective cohort study using administrative claims data. Int Clin Psychopharmacol. 2019;34(5):234-240.

9 Iketani R, Ohno K, Kawasaki Y, Matsumoto K, Yamada H, Kishino S. Apolipoprotein E Gene Polymorphisms Affect the Efficacy of Thiazolidinediones for Alzheimer’s Disease: A Systematic Review and Meta-Analysis. Biol Pharm Bull. 2018;41(7):1017-1023.

10 Iketani R, Kawasaki Y, Yamada H. Comparative Utility of Atypical Antipsychotics for the Treatment of Psychosis in Parkinson’s Disease: A Systematic Review and Bayesian Network Meta-analysis. Biol Pharm Bull. 2017;40(11):1976-1982.

Social contributions

・ Editorial board member (Social Pharmacy)

Others(Awards, etc.)

・ Outstanding Presentation Award (The 16th Annual Meeting of the Pharmacy Society of Japan)

・ Young Investigator’s Award (The 31st Annual Meeting of the Japanese Society of Pharmaceutical Health Care and Sciences)

・ Outstanding Presentation Award (The 134th Annual Meeting of the Pharmaceutical Society of Japan)